Advertisement
Screener

GENZYME CORP Sales Revenue, Services, Net (Deprecated 2018-01-31)

GENZYME CORP Sales Revenue, Services, Net (Deprecated 2018-01-31)

GENZYME CORP reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $45.29 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SalesRevenueServicesNet · last filed 2011-03-01

  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2010-12-31 was $13.12M, a 7.32% decline year-over-year.
  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2010-09-30 was $9.61M, a 8.32% decline year-over-year.
  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2010-06-30 was $103.59M, a 1.99% decline year-over-year.
  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2010-03-31 was $101.92M, a 0.41% increase year-over-year.
  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for fiscal 2010 was $45.29M, a 3.26% decline from fiscal 2009.
  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for fiscal 2009 was $46.82M, a 3.10% increase from fiscal 2008.
  • GENZYME CORP sales revenue, services, net (deprecated 2018-01-31) for fiscal 2008 was $45.41M.
Period endSales Revenue, Services, Net (Deprecated 2018-01-31) 3 monthSales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filedSales Revenue, Services, Net (Deprecated 2018-01-31) 6 monthSales Revenue, Services, Net (Deprecated 2018-01-31) 9 monthSales Revenue, Services, Net (Deprecated 2018-01-31) 9 month as first filedSales Revenue, Services, Net (Deprecated 2018-01-31) 12 monthSales Revenue, Services, Net (Deprecated 2018-01-31) 12 month as first filed
2010-12-31$13.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01
$22.73M
derived: sum of 2 quarters · filed 2011-03-01
$126.32M
derived: sum of 3 quarters · filed 2011-03-01
$45.29M
10-K · filed 2011-03-01
2010-09-30$9.61M
10-Q · filed 2010-11-09
$113.20M
derived: sum of 2 quarters · filed 2010-11-09
$32.17M
10-Q · filed 2010-11-09
$229.27M
derived: sum of 4 quarters · filed 2011-03-01
2010-06-30$103.59M
10-Q/A · filed 2010-09-07
$205.50M
10-Q/A · filed 2010-09-07
$219.66M
derived: sum of 3 quarters · filed 2011-03-01
$230.14M
derived: sum of 4 quarters · filed 2011-03-01
2010-03-31$101.92M
10-Q/A · filed 2010-05-11
$116.07M
derived: sum of 2 quarters · filed 2011-03-01
$126.55M
derived: sum of 3 quarters · filed 2011-03-01
$232.25M
derived: sum of 4 quarters · filed 2011-03-01
2009-12-31$14.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01
$24.64M
derived: sum of 2 quarters · filed 2011-03-01
$130.33M
derived: sum of 3 quarters · filed 2011-03-01
$46.82M
10-K · filed 2011-03-01
$418.52M
10-K · filed 2010-03-01
2009-09-30$10.48M
10-Q · filed 2010-11-09
$102.44M
10-Q · filed 2009-11-02
$116.17M
derived: sum of 2 quarters · filed 2010-11-09
$32.66M
10-Q · filed 2010-11-09
$309.63M
10-Q · filed 2009-11-02
-$5.99M
derived: sum of 4 quarters · filed 2011-03-01
2009-06-30$105.69M
10-Q/A · filed 2010-09-07
$207.19M
10-Q/A · filed 2010-09-07
-$16.47M
derived: sum of 3 quarters · filed 2011-03-01
$76.12M
derived: sum of 4 quarters · filed 2011-03-01
2009-03-31$101.50M
10-Q/A · filed 2010-05-11
-$122.16M
derived: sum of 2 quarters · filed 2011-03-01
-$29.58M
derived: sum of 3 quarters · filed 2011-03-01
$61.05M
derived: sum of 4 quarters · filed 2011-03-01
2008-12-31-$223.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01
-$131.08M
derived: sum of 2 quarters · filed 2011-03-01
-$40.45M
derived: sum of 3 quarters · filed 2011-03-01
$45.41M
10-K · filed 2011-03-01
$366.09M
10-K · filed 2010-03-01
2008-09-30$92.59M
10-Q · filed 2009-11-02
$183.21M
derived: sum of 2 quarters · filed 2009-11-02
$269.07M
10-Q · filed 2009-11-02
2008-06-30$90.62M
10-Q/A · filed 2009-09-04
$176.49M
10-Q/A · filed 2009-09-04
2007-12-31$326.33M
8-K · filed 2010-06-14